The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kilian, P. L.
Right arrow Articles by Lomedico, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kilian, P. L.
Right arrow Articles by Lomedico, P. T.

The Journal of Immunology, Vol 136, Issue 12 4509-4514, Copyright © 1986 by American Association of Immunologists


ARTICLES

Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells

PL Kilian, KL Kaffka, AS Stern, D Woehle, WR Benjamin, TM Dechiara, U Gubler, JJ Farrar, SB Mizel and PT Lomedico

Pure, E. coli-derived recombinant murine interleukin 1 alpha (IL 1 alpha) was labeled with 125I and used for receptor binding studies. The 125I-IL 1 binds to murine EL-4 thymoma cells in a specific and saturable manner. Scatchard plot analysis for binding studies carried out at 4 degrees C reveals a single type of high affinity binding site with an apparent dissociation constant of approximately 2.6 X 10(-10) M and the presence of approximately 1200 binding sites per cell. The rate of association of the 125I-IL 1 with EL-4 cells is slow, requiring more than 3 h to reach apparent steady state at 4 degrees C. Cell-bound 125I- IL 1 cannot be dissociated from EL-4 cells upon removal of unbound 125I- IL 1 and incubation of the cells at 4 degrees C in the presence or absence of unlabeled IL 1. Unlabeled recombinant murine IL 1 competes for 125I-IL 1 binding in a dose-dependent manner, whereas interferon- alpha A, interleukin 2 (IL 2), epidermal growth factor, and nerve growth factor have no effect. The 125I-IL 1 binding site is sensitive to trypsin, suggesting that it is localized on the cell surface. We have also examined the ability of purified recombinant human IL 1 alpha and IL 1 beta to compete for binding of the radiolabeled murine IL 1 to its receptor and to stimulate IL 2 production by EL-4 cells. Previous reports have shown that human IL 1 alpha is approximately 60% homologous in amino acid sequence with murine IL 1, but that human IL 1 beta is only about 25% homologous with either murine IL 1 or human IL 1 alpha. Despite these marked differences, however, we report here that both human IL 1 proteins are able to recognize the same binding site as mouse IL 1. In addition, murine as well as both human IL 1 proteins stimulate IL 2 production by EL-4 cells.


This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Saijo, M. Tanaka, M. Miki, K. Usui, T. Suzuki, M. Maemondo, X. Hong, R. Tazawa, T. Kikuchi, K. Matsushima, et al.
Proinflammatory Cytokine IL-1{beta} Promotes Tumor Growth of Lewis Lung Carcinoma by Induction of Angiogenic Factors: In Vivo Analysis of Tumor-Stromal Interaction
J. Immunol., July 1, 2002; 169(1): 469 - 475.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Yoshida, H. Sakamoto, T. Horiuchi, S. Yamamoto, A. Suematsu, H. Oda, and Y. Koshihara
Involvement of Prostaglandin E2 in Interleukin-1{{alpha}}-Induced Parathyroid Hormone-Related Peptide Production in Synovial Fibroblasts of Patients with Rheumatoid Arthritis
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3272 - 3278.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. J.H. Nicklin, D. E. Hughes, J. L. Barton, J. M. Ure, and G. W. Duff
Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist Gene
J. Exp. Med., January 17, 2000; 191(2): 303 - 312.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. H. Broide, K. Campbell, T. Gifford, and P. Sriramarao
Inhibition of eosinophilic inflammation in allergen-challenged, IL-1 receptor type 1-deficient mice is associated with reduced eosinophil rolling and adhesion on vascular endothelium
Blood, January 1, 2000; 95(1): 263 - 269.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Greenfeder, P. Nunes, L. Kwee, M. Labow, R. A. Chizzonite, and G. Ju
Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex
J. Biol. Chem., June 9, 1995; 270(23): 13757 - 13765.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
F Colotta, F Re, M Muzio, R Bertini, N Polentarutti, M Sironi, J. Giri, S. Dower, J. Sims, and A Mantovani
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
Science, July 23, 1993; 261(5120): 472 - 475.
[Abstract] [PDF]


Home page
ScienceHome page
J. Sims, C. March, D Cosman, M. Widmer, H. MacDonald, C. McMahan, C. Grubin, J. Wignall, J. Jackson, S. Call, et al.
cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily
Science, July 29, 1988; 241(4865): 585 - 589.
[Abstract] [PDF]


Home page
ScienceHome page
E. Unanue and P. Allen
The basis for the immunoregulatory role of macrophages and other accessory cells
Science, May 1, 1987; 236(4801): 551 - 557.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1986 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1986 by The American Association of Immunologists, Inc. All rights reserved.